1.20
+0(+0.00%)
Currency In USD
Address
444 West Lake Street
Chicago, IL 60606
United States of America
Phone
312 416 8592
Website
Sector
Healthcare
Industry
Biotechnology
Employees
13
First IPO Date
July 28, 2022
| Name | Title | Pay | Year Born |
| Dr. Vlad Vitoc M.B.A., M.D. | Co-Founder, President, Chief Executive Officer & Chairman of the Board of Directors | 722,961 | 1970 |
| Mr. Jeffrey C. Himmelreich | Head of Finance and Principal Financial & Accounting Officer | 306,500 | 1976 |
| Dr. Sergei M. Gryaznov Ph.D. | Chief Scientific Officer | 521,661 | 1960 |
| Linda Moreira | Company Secretary | 0 | N/A |
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.